Influence
March 21, 2022

Revolutionizing research through pragmatic trials

Regenstrief Institute Research Scientist Kathleen Unroe, M.D., MHA, M.S., is at the forefront of the next generation of research methodology: pragmatic trials. Pragmatic trials are designed to evaluate the effectiveness of interventions in real-life practice, speeding up the time from discovery to implementation.  

Dr. Unroe, along with Regenstrief faculty member Susan Hickman, PhD, is leading one of few pragmatic trials funded by the National Institute on Aging. The APPROACHES (Aligning Patient Preferences – a Role Offering Alzheimer’s patients, Caregivers, and Healthcare providers Education and Support) trial is being conducted in 150 nursing homes, testing an intervention to support advance care planning.  

She is also part of the IMPACT Collaboratory, a research incubator to develop pragmatic trials and train researchers to design and execute them.  

In 2021, Dr. Unroe spoke at a conference about pragmatic trials in long-term care facilities. The event identified priorities and best practices for trials taking place in these real-world settings. 

Dr. Unroe says she is excited about the potential of pragmatic trials for creating solutions as well as creating partnerships between researchers and healthcare systems.  

In addition to being a research scientist in the IU Center for Aging Research at Regenstrief Institute, Dr. Unroe is an associate professor at the IU School of Medicine and a practicing geriatrician. 

  • Kathleen Unroe

Related News

infographic showing findings of study

Examining how insurance coverage shapes access to kidney transplantation

Regenstrief researchers contribute to a national study highlighting differences between Medicare Advantage and traditional Medicare  For people with kidney

Tarik Yuce, MD, Jiang Bian, PhD, Serena Guo, MD, PhD, Xing He, PhD, Yu Huang, PhD

GLP-1 medications linked to greater loss of regained weight after bariatric surgery

Study involving Regenstrief researchers uses real-world evidence to evaluate an option for managing weight recurrence  People who regain weight

image of a doctor consulting with a patient

Scalable approach could improve early detection of cognitive impairment in primary care

Regenstrief-led study evaluates how existing health data and patient-reported information could help clinicians identify individuals who need further assessmentEarly

Christopher Callahan, MD

Regenstrief Institute scientist named next president and CEO of Regenstrief Foundation 

Longtime Regenstrief investigator and former IU Center for Aging Research director will assume Foundation leadership in summer 2027.  Christopher